|Videos|May 7, 2017

What Are the Alternatives to Contact Precautions for C. diff Patients?

Gonzalo Bearman, MD, MPH, professor of medicine, and hospital epidemiologist, Department of Internal Medicine and Infectious Diseases, Virginia Commonwealth University, discusses some alternative approaches to contact precautions for patients with Clostridium difficile.

Gonzalo Bearman, MD, MPH, professor of medicine, and hospital epidemiologist, Department of Internal Medicine and Infectious Diseases, Virginia Commonwealth University, discusses some alternative approaches to contact precautions for patients with Clostridium difficile.

Interview Transcript (slightly modified for readability)

“I think that an alternative to contact precautions for Clostridium difficile would be, first, be very aggressive with your hand washing, your disinfection of the environment, either with bleach or even using some of the new technologies, such as UVC technologies, or robots, or UVC light technologies. Instead of isolating everyone, for example, with active detection and isolation, minimizing the use of contact precautions just for people who are truly infected.”


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.